Literature DB >> 7822737

Neuropathology of Rett syndrome: case report with neuronal and mitochondrial abnormalities in the brain.

M E Cornford1, M Philippart, B Jacobs, A B Scheibel, H V Vinters.   

Abstract

Neuronal changes in the brain of a Rett syndrome patient were examined in a frontal lobe biopsy performed at age 3 years and in the postmortem brain at age 15 years. In the brain biopsy, frontal cortex contained numerous scattered pyramidal neurons with cytoplasmic vacuolation and increased cytoplasmic density, with no neuronophagia or inflammation detected; electron microscopy showed these neurons to have large, lucent-appearing mitochondria, very abundant ribosomal content, and some lipofuscin granules. Postmortem brain 12 years later showed scattered neurons in frontal cortex, substantia nigra, and cerebellar folia, with increased electron density of the cytoplasm, stacks of ribosomal endoplasmic reticulum, and large amounts of disorganized membranous material, including autophagic-type organelles. Mitochondria of these neurons contained electron-dense, finely granular matrix inclusions; in the substantia nigra, some spherical mitochondrial inclusions completely filled the matrix space. Golgi preparations of (autopsy) frontal cortex and cerebellar folia showed truncation and thickening of dendrites and a degenerate appearance of cortical pyramidal neurons, similar to changes found in aged brain. Synaptophysin immunohistochemistry indicated that the density of synapses was not greatly altered compared to controls in frontal cortex and cerebellum. The patient also had a second genetic defect, severe combined immunodeficiency with thymic aplasia, which may be X-linked.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7822737     DOI: 10.1177/088307389400900419

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  26 in total

Review 1.  Transient receptor potential channels as novel effectors of brain-derived neurotrophic factor signaling: potential implications for Rett syndrome.

Authors:  Michelle D Amaral; Christopher A Chapleau; Lucas Pozzo-Miller
Journal:  Pharmacol Ther       Date:  2006-11-21       Impact factor: 12.310

Review 2.  Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders.

Authors:  Richard E Frye; Daniel A Rossignol
Journal:  Pediatr Res       Date:  2011-05       Impact factor: 3.756

3.  Oxidative stress in Rett syndrome: natural history, genotype, and variants.

Authors:  Silvia Leoncini; Claudio De Felice; Cinzia Signorini; Alessandra Pecorelli; Thierry Durand; Giuseppe Valacchi; Lucia Ciccoli; Joussef Hayek
Journal:  Redox Rep       Date:  2011       Impact factor: 4.412

4.  Mitochondrial dysfunction in CA1 hippocampal neurons of the UBE3A deficient mouse model for Angelman syndrome.

Authors:  Hailing Su; Weiwei Fan; Pinar E Coskun; Jouni Vesa; June-Anne Gold; Yong-Hui Jiang; Prasanth Potluri; Vincent Procaccio; Allan Acab; John H Weiss; Douglas C Wallace; Virginia E Kimonis
Journal:  Neurosci Lett       Date:  2009-06-27       Impact factor: 3.046

5.  CREB Signaling Is Involved in Rett Syndrome Pathogenesis.

Authors:  Qian Bu; Anxin Wang; Hamdi Hamzah; Alex Waldman; Keer Jiang; Qiping Dong; Ronghui Li; Jason Kim; Daniel Turner; Qiang Chang
Journal:  J Neurosci       Date:  2017-03-07       Impact factor: 6.167

6.  Developmental regression and mitochondrial dysfunction in a child with autism.

Authors:  Jon S Poling; Richard E Frye; John Shoffner; Andrew W Zimmerman
Journal:  J Child Neurol       Date:  2006-02       Impact factor: 1.987

7.  Rett syndrome.

Authors:  M Ghofrani; T Mahmoodian
Journal:  Indian J Pediatr       Date:  2000-07       Impact factor: 1.967

8.  Modulation of RhoGTPases improves the behavioral phenotype and reverses astrocytic deficits in a mouse model of Rett syndrome.

Authors:  Bianca De Filippis; Alessia Fabbri; Daiana Simone; Rossella Canese; Laura Ricceri; Fiorella Malchiodi-Albedi; Giovanni Laviola; Carla Fiorentini
Journal:  Neuropsychopharmacology       Date:  2011-12-07       Impact factor: 7.853

9.  Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons.

Authors:  Yun Li; Haoyi Wang; Julien Muffat; Albert W Cheng; David A Orlando; Jakob Lovén; Show-Ming Kwok; Danielle A Feldman; Helen S Bateup; Qing Gao; Dirk Hockemeyer; Maisam Mitalipova; Caroline A Lewis; Matthew G Vander Heiden; Mriganka Sur; Richard A Young; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2013-10-03       Impact factor: 24.633

10.  Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain.

Authors:  Joanne H Gibson; Barry Slobedman; Harikrishnan K N; Sarah L Williamson; Dimitri Minchenko; Assam El-Osta; Joshua L Stern; John Christodoulou
Journal:  BMC Neurosci       Date:  2010-04-26       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.